Shi Li

417 total citations
19 papers, 344 citations indexed

About

Shi Li is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Shi Li has authored 19 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Cell Biology. Recurrent topics in Shi Li's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Shi Li is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Shi Li collaborates with scholars based in China. Shi Li's co-authors include Jianling Xia, Xiangjian Chen, Ming Zeng, Hua Zhu, Lingyan Shi, Xiaoli Wu, Wei‐Fen Xie, Xingrong Zhang, Yue-Xiang Chen and Yao Shi and has published in prestigious journals such as Molecular Cancer, Biomedicine & Pharmacotherapy and Journal of Cellular and Molecular Medicine.

In The Last Decade

Shi Li

19 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shi Li China	10	246	155	61	43	36	19	344
Diyuan Zhou China	11	213 0.9×	115 0.7×	57 0.9×	60 1.4×	32 0.9×	19	310
Changjiang Lei China	13	266 1.1×	196 1.3×	52 0.9×	52 1.2×	38 1.1×	26	384
Jie Bao China	10	321 1.3×	258 1.7×	33 0.5×	44 1.0×	37 1.0×	16	385
Kefeng Lei China	9	251 1.0×	141 0.9×	39 0.6×	75 1.7×	23 0.6×	20	364
Jingpei Long China	10	290 1.2×	213 1.4×	40 0.7×	74 1.7×	16 0.4×	16	386
Ayumi Ando Japan	8	218 0.9×	112 0.7×	43 0.7×	23 0.5×	24 0.7×	11	306
Yimin Xiong China	10	248 1.0×	153 1.0×	20 0.3×	59 1.4×	40 1.1×	16	375

Countries citing papers authored by Shi Li

Since Specialization

Citations

This map shows the geographic impact of Shi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Li more than expected).

Fields of papers citing papers by Shi Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Li. The network helps show where Shi Li may publish in the future.

Co-authorship network of co-authors of Shi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Li. A scholar is included among the top collaborators of Shi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Li. Shi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zhang, Fenglin, et al.. (2025). Novel Mitochondria-Targeted NIR Cyanine Cy750M-C1 Nanoparticles for Chemotherapy against Triple-Negative Breast Cancer. ACS Biomaterials Science & Engineering. 11(6). 3738–3751. 1 indexed citations

Bao, Wenming, Xiaozai Xie, Bo Chen, et al.. (2024). Liensinine inhibits progression of intrahepatic cholangiocarcinoma by regulating TGF‐β1 /P‐smad3 signaling through HIF‐1a. Molecular Carcinogenesis. 63(4). 772–784. 4 indexed citations

Li, Shi, et al.. (2023). Risk Evaluation of Bone Metastases and a Simple Tool for Detecting Bone Metastases in Prostate Cancer: A Population‐Based Study. Computational and Mathematical Methods in Medicine. 2023(1). 9161763–9161763. 4 indexed citations

Li, Shi, Zhi Wang, Jianling Xia, et al.. (2023). Glucose dysregulation promotes oncogenesis in human bladder cancer by regulating autophagy and YAP1/TAZ expression. Journal of Cellular and Molecular Medicine. 27(23). 3744–3759. 6 indexed citations

Xu, Haiting, Xuwei Zhu, Shi Li, Nan Lin, & Xiaoyang Li. (2021). miR-383-5p inhibits human malignant melanoma cells function via targeting CENPF. Reproductive Biology. 21(3). 100535–100535. 5 indexed citations

Yue, Zhiyong, et al.. (2021). Downregulation of miR-204 facilitates the progression of nasopharyngeal carcinoma by targeting CXCR4 through NF-κB signaling pathway.. PubMed. 25(2). 1098–1104. 6 indexed citations

Li, Shi, et al.. (2020). Glucose promotes epithelial‐mesenchymal transitions in bladder cancer by regulating the functions of YAP1 and TAZ. Journal of Cellular and Molecular Medicine. 24(18). 10391–10401. 22 indexed citations

Pu, Tianjie, Shi Li, Libo Yang, et al.. (2019). Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP. Laboratory Investigation. 99(9). 1296–1308. 19 indexed citations

Wang, Hongqiang, Yan Guo, Lin Shui, et al.. (2019). HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 324–324. 31 indexed citations

10.

Chen, Xing-Xing, Shi Li, Zhe Yu, & Wanlong Tan. (2019). Yes-associated protein 1 promotes bladder cancer invasion by regulating epithelial-mesenchymal transition.. PubMed. 12(3). 1070–1077. 7 indexed citations

11.

Xia, Lingling, Shi Li, Yang Liu, et al.. (2019). NDNF inhibits the migration and invasion of human renal cancer cells through epithelial‑mesenchymal transition. Oncology Letters. 17(3). 2969–2975. 11 indexed citations

12.

Xia, Jianling, Hongqiang Wang, Shi Li, et al.. (2017). Ion channels or aquaporins as novel molecular targets in gastric cancer. Molecular Cancer. 16(1). 54–54. 51 indexed citations

13.

Wu, Xiaoli, et al.. (2017). Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway. Biomedicine & Pharmacotherapy. 96. 1103–1108. 67 indexed citations

14.

Xia, Jianling, et al.. (2017). Emerging role of Hippo signalling pathway in bladder cancer. Journal of Cellular and Molecular Medicine. 22(1). 4–15. 32 indexed citations

15.

Wei, Wei, Shi Li, Weichang Chen, et al.. (2017). miR-200c regulates the proliferation, apoptosis and invasion of gastric carcinoma cells through the downregulation of EDNRA expression. International Journal of Molecular Medicine. 41(3). 1619–1626. 14 indexed citations

16.

Shi, Yao, Chen Lv, Shi Li, & Guanjun Tu. (2017). MEG3 inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells. Oncology Letters. 15(2). 1917–1923. 29 indexed citations

17.

Chen, Yue-Xiang, Siwen Chen, Xingrong Zhang, et al.. (2005). [Inhibition of proliferation of hepatic stellate cells by taurine is mediated via regulating cell cycle proteins].. PubMed. 13(8). 571–4. 1 indexed citations

18.

Chen, Yue-Xiang, Xingrong Zhang, Wei‐Fen Xie, & Shi Li. (2004). Effects of taurine on proliferation and apoptosis of hepatic stellate cells in vitro.. PubMed. 3(1). 106–9. 33 indexed citations

19.

Li, Shi. (1998). Studies on the Development of Male- and Female- Gametophytes and Callose Deposit Dynamics in Anmearrhean asphodeloides. Acta Botanica Yunnanica. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diyuan Zhou Breakdown of academic impact, for papers by Changjiang Lei Breakdown of academic impact, for papers by Jie Bao Breakdown of academic impact, for papers by Kefeng Lei Breakdown of academic impact, for papers by Jingpei Long Breakdown of academic impact, for papers by Ayumi Ando Breakdown of academic impact, for papers by Yimin Xiong